Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

Allergan stumps up $375m for bolt-on acquisitions

Allergan stumps up $375m for bolt-on acquisitions days. Fresh from its $70bn takeover by Actavis (which promptly assumed its name), Allergan will pay $250m upfront to take over ownership of two calcitonin gene-related peptide (CGRP) receptor antagonists

Abcam appoints chief legal officer and company secretary

Abcam appoints chief legal officer and company secretary She previously held the role of executive director of legal at Actavis, where she held responsibility for the leadership of the firm's international legal function.

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera The latest deal comes as Allergan is still in the aftermath of a $70bn takeover by Actavis, which completed in March, as well as the official change in trading name for ... Kythera's shareholders still need to vote on the transaction. Last year Valeant -

More waiting for Allergan and Gedeon Richter's antipsychotic

More waiting for Allergan and Gedeon Richter's antipsychotic North American rights to the drug were bought by Forest Labs, acquired last year by Actavis, which in turn merged with Allergan and officially adopted the latter company's name.

Takeda files block on generic diet pill launch

Takeda files block on generic diet pill launch Orexigen and its partner Takeda have taken Actavis to court to block a generic version of the firms' diet pill Contrave. ... Actavis and Teva have both already filed for marketing approval of Qsymia's copycat version.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...